Syngle Tx successfully completes proof-of-concept in Parkinson’s animal model
Syngle Therapeutics is developing a vectorized antibody treatment for Parkinson’s disease. This revolutionary approach has now been successfully tested in an acute Parkinson’s animal model demonstrating neuroprotection and positive effects on motor symptoms.
Read more “Syngle Tx successfully completes proof-of-concept in Parkinson’s animal model”